Nvest Wealth Strategies’s Guardant Health GH Stock Holding History

Nvest Wealth Strategies’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301	Buy	+2	New	+$218	﹤0.01%	329

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nvest Wealth Strategies's GH Position: Q2 2026 in Review

Nvest Wealth Strategies opened a new position in Guardant Health (GH) in Q2 2026: 2 shares worth $301. The stake represents ﹤0.01% of the portfolio and ranks #329 among its holdings.

246 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Nvest Wealth Strategies held 2 shares of Guardant Health worth $301 as of Q2 2026.
Guardant Health was a new Nvest Wealth Strategies position in Q2 2026.
Guardant Health made up ﹤0.01% of Nvest Wealth Strategies's portfolio in Q2 2026, its #329 holding.
246 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.